Merging Expertise & Strength

PCT's management team has an unprecedented level of experience in cell therapy, has built 5 cGMP facilities, and has participated in over 50 regulatory filings in the U.S. and Europe. PCT has served over 100 Clients, worked on over 20 types of cells and tissues, and performed over 30,000 cell therapy procedures, more than 6,000 of which have already been used for patient treatment.

Robin Smith, M.D., M.B.A. / NeoStem Chairman & CEO

Dr. Robin L. Smith has served as Chairman and Chief Executive Officer of NeoStem, PCT’s parent company, since 2006. Leveraging her expertise in medicine and business development, Dr. Smith has positioned NeoStem as a leader in the emerging stem cell industry, built on a successful business model that combines a proprietary therapeutic development business with PCT’s successful contract development and manufacturing services.

Complete Bio

Robert A. Preti, Ph.D. / President & Chief Scientific Officer

Robert “Bob” Preti is PCT’s co-founder and the visionary behind its successful growth and development strategy over much of the last two decades. Bob built PCT to meet a recognized need for high quality manufacturing and development services in an emerging industry.

Complete Bio

Andrew Pecora, M.D. / Chief Medical Officer

As Co-Founder and Chief Medical Officer of PCT, Dr. Andrew Pecora has played a lead role in shaping the vision and direction of PCT’s dynamic growth over the past two decades. His medical and scientific expertise, combined with his business development and healthcare management background, have made Andrew an invaluable pillar of PCT and its Client-focused development and manufacturing operations.

Complete Bio

George S. Goldberger, M.B.A. / Vice President, Business Development

George S. Goldberger is PCT’s Vice President of Business Development. Prior to the acquisition of PCT by NeoStem, he was PCT’s Chief Business and Financial Officer.

Complete Bio
Robert_Shaw

Robert Shaw, M.B.A. / Vice President, Commercial Development

Bob Shaw is Vice President, Commercial Development of PCT, tasked with PCT’s growth through strategic transactions and additional business lines, as well growing the existing Client base through enhanced technical sales and marketing initiatives.

Complete Bio
Mark_Westgate

Mark Westgate / Vice President, Finance

Mark Westgate is Vice President of Finance. Mark is responsible for the oversight and coordination of all accounting and finance functions at PCT, playing a key role in managing the company’s continued growth and in reporting results to the public markets as part of Neostem. He participates in business development, client and investor relationship activities.

Complete Bio
Brian_Hampson

Brian Hampson / Vice President, Engineering & Innovation

Brian Hampson is Vice President, Engineering & Innovation, tasked with leading PCT’s newly created Engineering & Innovation department (E&I).

Complete Bio